Attached files
| file | filename |
|---|---|
| 10-K - Protagenic Therapeutics, Inc.\new | v178944_10k.htm |
| EX-23.1 - Protagenic Therapeutics, Inc.\new | v178944_ex23-1.htm |
| EX-31.1 - Protagenic Therapeutics, Inc.\new | v178944_ex31-1.htm |
| EX-31.2 - Protagenic Therapeutics, Inc.\new | v178944_ex31-2.htm |
| EX-21.1 - Protagenic Therapeutics, Inc.\new | v178944_ex21-1.htm |
| EX-10.21 - Protagenic Therapeutics, Inc.\new | v178944_ex10-21.htm |
| EX-10.20 - Protagenic Therapeutics, Inc.\new | v178944_ex10-20.htm |
| EX-10.22 - Protagenic Therapeutics, Inc.\new | v178944_ex10-22.htm |
| EX-10.23 - Protagenic Therapeutics, Inc.\new | v178944_ex10-23.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18 U.S.C.
SECTION 1350
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, in connection with the filing of the Annual Report
on Form 10-K for the Year Ended December 31, 2009 (the "Report") by Atrinsic,
Inc. ("Registrant"), each of the undersigned hereby certifies that, to the best
of their knowledge:
|
1.
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of
Registrant.
|
|
Date:
March 30, 2010
|
/s/
Jeffrey Schwartz
|
|
Jeffrey
Schwartz
|
|
|
Chief
Executive Officer
|
|
|
Date:
March 30, 2010
|
/s/
Thomas Plotts
|
|
Thomas
Plotts
|
|
|
Chief
Financial Officer (Interim)
|
A signed
original of this written statement required by Section 906 has been provided to
Atrinsic, Inc. and will be retained by Atrinsic, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.
EX-7